From: Clonidine in the treatment of adolescent chronic fatigue syndrome: a pilot study for the NorCAPITAL trial
Number (male/female)
5 (3/2)
Median (range)
Age (years)
14
(14–19)
BMI (kg/m2)
20.8
(17.0-22.4)
Disease duration (months)
34
(27–48)
C0 of clonidine (μg/L),
0.21
(0.18-0.36)
Cmax of clonidine (μg/L)
0.41
(0.38-0.56)